Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
November 1st, 2017 |
George M. O'Brien Kidney Research Core Centers (P30) |
National Institutes of Health |
August 1st, 2017 |
Dysregulation of Immune Cell Regulatory Pathways by Mtb in the Context of HIV Infection (R61/R33) |
National Institutes of Health |
April 28th, 2017 |
DREAMS Initiative Namibia |
South Africa USAID Pretoria |
June 5th, 2017 |
Data to Care Rx: Using Real-time Prescription Claims Data to Support the HIV Care Continuum |
Centers for Disease Control NCHHSTP |
July 20th, 2017 |
Resource Centers for Minority Aging Research (P30) |
National Institutes of Health |
July 20th, 2017 |
Alzheimer's-related Resource Centers for Minority Aging Research (AD-RCMAR) (P30) |
National Institutes of Health |
July 20th, 2017 |
Resource Centers for Minority Aging (RCMAR) Coordinating Center (R24) |
National Institutes of Health |
July 18th, 2017 |
FY2017 Lifespan Respite Care Program: Advancing State Lifespan Respite Systems |
Administration for Community Living |
June 28th, 2017 |
Agriculture and Food Research Initiative - Childhood Obesity Prevention Challenge Area |
National Institute of Food and Agriculture |
May 28th, 2019 |
Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30) |
National Institutes of Health |
January 15th, 2020 |
Extracellular Vesicles and Substance Use Disorders (R01) |
National Institutes of Health |
May 7th, 2020 |
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01) |
National Institutes of Health |
June 7th, 2017 |
Addressing Ebola and other Highly Infectious Diseases Internationally |
Centers for Disease Control CGH |
July 16th, 2019 |
Health Information Technology (IT) to Improve Health Care Quality and Outcomes (R21) |
Agency for Health Care Research and Quality |
January 15th, 2020 |
Extracellular Vesicles and Substance Use Disorders (R21) |
National Institutes of Health |
May 7th, 2020 |
Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01) |
National Institutes of Health |
June 15th, 2017 |
Activities to Promote Research Collaborations on Immune-Related Adverse Events (APRC-irAEs) Associated with Cancer Immunotherapy (Admin Supp) |
National Institutes of Health |
September 25th, 2019 |
Implementation and Evaluation of New Health Information Technology (IT) Strategies for Collecting and Using Patient-Reported Outcome (PRO) Measures (U18) |
Agency for Health Care Research and Quality |
June 29th, 2017 |
Centers of Excellence for Training in Glycosciences (K12) |
National Institutes of Health |
April 27th, 2017 |
COPY OF Sustained Strengthening of Public Health Laboratory, Transfusion Services, and Health Care Worker Infection Control Practices for Ebola Virus Disease in Liberia |
Centers for Disease Control CGH |
|
May 31st, 2017 |
Increasing Newborn Screening Laboratory Capability to Detect Severe Combined Immunodeficiency (SCID) Using Next Generation Sequencing Technologies |
Centers for Disease Control NCEH |
July 6th, 2017 |
Establishment of Research Centers to Investigate the FVIII Immune Response in Patients with Hemophilia A (U54) |
National Institutes of Health |
May 7th, 2020 |
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21) |
National Institutes of Health |
May 7th, 2020 |
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01) |
National Institutes of Health |
November 13th, 2019 |
Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2) |
National Institutes of Health |
April 28th, 2017 |
Fostering Research Training and Education Programs for Native American Students at NCI-designated Cancer Centers (Admin Supp) |
National Institutes of Health |
May 30th, 2017 |
Neurosurgeon Research Career Development Program (NRCDP) (K12) |
National Institutes of Health |
August 17th, 2019 |
Developmental Centers for AIDS Research (P30) |
National Institutes of Health |
August 17th, 2019 |
Centers for AIDS Research (P30) |
National Institutes of Health |
July 12th, 2017 |
Building Capacity of the Public Health System to Improve Population Health through National, Nonprofit Organizations, financed in part by 2017 Prevention and Public Health Funds |
Centers for Disease Control OSTLTS |
December 5th, 2017 |
Secure Data Sharing Tool to Support De-duplication of Cases in the National HIV Surveillance System (NHSS) |
Centers for Disease Control NCHHSTP |
July 11th, 2019 |
Mechanisms and Consequences of Sleep Disparities in the U.S. (R01) |
National Institutes of Health |
July 11th, 2019 |
Mechanisms and Consequences of Sleep Disparities in the U.S. (R21) |
National Institutes of Health |
November 5th, 2019 |
Genetic Susceptibility and Variability of Human Structural Birth Defects (R01) |
National Institutes of Health |
January 5th, 2020 |
Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R43) |
National Institutes of Health |
May 7th, 2020 |
Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01) |
National Institutes of Health |
January 5th, 2020 |
Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R41) |
National Institutes of Health |
May 21st, 2020 |
Innovative Research in Cancer Nanotechnology (IRCN) (R01) |
National Institutes of Health |
April 28th, 2017 |
Pan American Health Organization (PAHO) Building Capacity and Networks to Address Emerging Infectious Diseases in the Americas (CK-1301-04SUPP2017) |
Centers for Disease Control NCEZID |
May 7th, 2020 |
Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R21) |
National Institutes of Health |